This review focuses on the cell-surface pro-HGF activation system in urological cancers, including prostate cancer (PC), renal cell carcinoma (RCC), and urothelial carcinoma (UC) of bladder, and summarizes its significance in the progression of cancer. The gene discussed is HGF; the disease is cancer.